Crossmark

Optimal remimazolam dosage for pediatric painless gastrointestinal endoscopy: a randomized controlled trial comparing efficacy and safety of three doses combined with sufentanil and propofol

Crossref DOI link: https://doi.org/10.1186/s12871-025-03511-2

Published Online: 2026-01-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Wenjing

Shi, Lei

Bao, Wenjuan

Liu, Yang

Shi, Jing
License Information

Text and Data Mining valid from 2026-01-02

Version of Record valid from 2026-02-02
More Information

Article History

Received: 6 August 2025

Accepted: 13 November 2025

First Online: 2 January 2026

Declarations

:

: The study was approved by the Ethics Committee of Hebei Children’s Hospital. Written informed consent was obtained from parents/guardians and assent from children where appropriate.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below